Oral peptide with biologics-like high potency and spectrum of activity against three therapeutically relevant dimeric forms of IL-17 (AA, AF…
Renewed multi-year partnership to support Ferring Pharmaceuticals' operations in response to rapid business growth NEW YORK, Nov. 21, 2024 /PRNewswire/…
Conference call and webcast: today, November 21, 2024, 9:00 am ET Financial Highlights: In the first nine months of 2024,…
Setting a Quality & Compliance Foundation for Life Sciences Firms to Leverage Technological Advancements ISELIN, N.J., Nov. 21, 2024 /PRNewswire/…
Enhanced integration fuels the rapid growth of this first-of-its kind platform and related initiative between Outcomes4Me and NCCN, leveraging technology to…
CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company focused on…
MIAMI, FL / ACCESSWIRE / November 21, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) ("Telomir" or the "Company"), an emerging leader…
Workshop, poster and oral presentation of data given as part of the 8th Annual Antifibrotic Drug Development (AFDD) Summit Data…
Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable TherapeuticsJUPITER, Fla., Nov. 21, 2024 (GLOBE…
New patents position Biomerica to address multi-billion-dollar markets in Europe, including GERD ($4 billion+), Crohn’s Disease ($2.5 billion+), and Ulcerative…